Traded Nov 17, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 22, 2025 · Filed Oct 24, 2025
A Vicor director sold $29K of Vicor shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$28,552
Shares × reported transaction price
1 day after results of Oct 21, 2025, 120 days before results of Feb 19, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.7% | −0.3% | +4.0% |
| 30 days | −0.5% | −0.8% | +0.3% |
| 90 days | +76.1% | +1.1% | +75.0% |
| 180 days | +198.5% | +4.4% | +194.1% |
Past results only. Not a forecast.
Traded Nov 17, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Andrew D'amico (Director) sold ~$175K of Vicor Corporation
Scheduled in advanceTraded Nov 17, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.